MedTrace Logo

Misoprostol For Nulliparous Women Before Hysteroscopy

NCT01156948 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2010-07-08

No results posted yet for this study

Summary

To compare the impact of 400-microgram self-administered vaginal versus self-administered oral misoprostol at home on preoperative cervical ripening in nulliparous women prior to outpatient hysteroscopy.

Conditions

  • Cervical Ripening

Interventions

DRUG

misoprostol

400ug vaginally the day before surgery

DRUG

oral misoprostol

400ug misoprostol orally the day before the surgery

Sponsors & Collaborators

  • Wenzhou Medical University

    lead OTHER

Principal Investigators

  • Feng Lin · the 1st affiliated hospital of Wenzhou Medical College

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-05-31
Primary Completion
2010-08-31
Completion
2011-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01156948 on ClinicalTrials.gov